Prominex
San Diego
About Prominex
Prominex is moving forward with ambitions to develop a 5-minute SARS-CoV-2 test on their point-of-care molecular diagnostic platform. The company is dedicated to increasing access to low-cost, quick infectious disease diagnostics for STIs and respiratory illnesses. Our SARS-CoV-2 test provides accurate results in 5 minutes, allowing healthcare practitioners to make more informed treatment and infection management decisions. devoted to increasing access to low-cost, quick infectious disease tests for STIs and respiratory illnesses. Our SARS-CoV-2 test provides accurate results in 5 minutes, allowing healthcare practitioners to make more informed treatment and infection management decisions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2018)
- Website: prominex.com
- Phone: 858 242-1541
Industries & Categories
Biotechnology, Manufacturing
Canonical: https://fsome.com/organization/prominex-64167 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.